A Placebo-Controlled Trial of Atomoxetine in Marijuana-Dependent Individuals with Attention Deficit Hyperactivity Disorder

被引：59
|
作者：
McRae-Clark, Aimee L. [1 ]
Carter, Rickey E. [2 ]
Killeen, Therese K. [1 ]
Carpenter, Matthew J. [1 ]
White, Kathleen G. [1 ]
Brady, Kathleen T. [1 ]
机构：
[1] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
AMERICAN JOURNAL ON ADDICTIONS | 2010年 / 19卷 / 06期
关键词：
DEFICIT/HYPERACTIVITY DISORDER; SUBSTANCE-ABUSE; ADULT ADHD; SUBTHRESHOLD DIAGNOSES; LATE-ONSET; FOLLOW-UP; ALCOHOL; METHYLPHENIDATE; COMORBIDITY; COGNITION;
D O I：
10.1111/j.1521-0391.2010.00076.x
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
This study evaluated the effects of atomoxetine on the symptoms of attention deficit hyperactivity disorder (ADHD) and marijuana use in marijuana-dependent adults. In conjunction with motivational interviewing, participants received either atomoxetine (n = 19) or matching placebo (n = 19) for 12 weeks. Participants randomized to atomoxetine had greater improvement in ADHD on the Clinical Global Impression-Improvement scale than participants treated with placebo. No treatment group differences in self-rated ADHD symptoms, overall Wender-Reimherr Adult Attention Deficit Disorder Scale scores, or marijuana use outcomes were noted. These results suggest that atomoxetine may improve some ADHD symptoms but does not reduce marijuana use in this population. (Am J Addict 2010;00:1-9).
引用
收藏
页码：481 / 489
页数：9
相关论文
共 50 条
  • [1] Randomized, Controlled Trial of Atomoxetine for Attention-Deficit/Hyperactivity Disorder in Adolescents With Substance Use Disorder
    Thurstone, Christian
    Riggs, Paula D.
    Salomonsen-Sautel, Stacy
    Mikulich-Gilbertson, Susan K.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 49 (06) : 573 - 582
  • [2] Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials
    Asherson, Philip
    Bushe, Chris
    Saylor, Keith
    Tanaka, Yoko
    Deberdt, Walter
    Upadhyaya, Himanshu
    JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (09) : 837 - 846
  • [3] A Randomized Placebo-Controlled Trial of Electroencephalographic (EEG) Neurofeedback in Children With Attention-Deficit/Hyperactivity Disorder
    van Dongen-Boomsma, Martine
    Vollebregt, Madelon A.
    Slaats-Willemse, Dorine
    Buitelaar, Jan K.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (08) : 821 - 827
  • [4] Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
    Sallee, Floyd R.
    McGgough, James
    Wigal, Tim
    Donahue, Jessica
    Lyne, Andrew
    Biederman, Joseph
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (02) : 155 - 165
  • [5] Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial
    Riahi, Forough
    Tehrani-Doost, Mehdi
    Shahrivar, Zahra
    Alaghband-Rad, Javad
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (7-8) : 570 - 576
  • [6] Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial
    Shaywitz, Sally
    Shaywitz, Bennett
    Wietecha, Linda
    Wigal, Sharon
    McBurnett, Keith
    Williams, David
    Kronenberger, William G.
    Hooper, Stephen R.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (01) : 19 - 28
  • [7] Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
    Martenyi, Ferenc
    Zavadenko, Nikolay N.
    Jarkova, Natalia B.
    Yarosh, Alexandr A.
    Soldatenkova, Victoria O.
    Bardenstein, Leonid M.
    Kozlova, Irina A.
    Neznanov, Nikolay G.
    Maslova, Olga I.
    Petrukhin, Andrey S.
    Sukchotina, Nina K.
    Zykov, Valeriy P.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2010, 19 (01) : 57 - 66
  • [8] Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials
    Maneeton, Narong
    Maneeton, Benchalak
    Srisurapanont, Manit
    Martin, Stephen D.
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 65 (07) : 611 - 617
  • [9] Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study
    Dell'Agnello, Grazia
    Maschietto, Dino
    Bravaccio, Carmela
    Calamoneri, Filippo
    Masi, Gabriele
    Curatolo, Paolo
    Besana, Dante
    Mancini, Francesca
    Rossi, Andrea
    Poole, Lynne
    Escobar, Rodrigo
    Zuddas, Alessandro
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (11) : 822 - 834
  • [10] Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial
    Adler, Lenard A.
    Goldman, Robert
    Hopkins, Seth C.
    Koblan, Kenneth S.
    Kent, Justine
    Hsu, Jay
    Loebel, Antony
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 117 - 125
12345